AGXT and primary hyperoxaluria type 1: Genetically, PH1 is a life-threatening syndrome caused by the AGXT gene mutation, resulting in decreased activity of hepatic enzyme alanine-glyoxylate aminotransferase (AGT), which catalyzes glyoxylate conversion to glycine (Hopp et al., 2015; Zabaleta et al., 2018).